NCT03521752 is a NA clinical trial of Specific Exercise Program in Balance; Distorted, sponsored by Cooperativa de Ensino Superior, Politécnico e Universitário.

Who is sponsoring NCT03521752?

NCT03521752 is sponsored by Cooperativa de Ensino Superior, Politécnico e Universitário.

What drugs are being tested in NCT03521752?

Interventions in NCT03521752: Specific Exercise Program.

What condition does NCT03521752 study?

NCT03521752 studies Balance; Distorted.

Is NCT03521752 still recruiting?

NCT03521752 is currently completed. Last updated 16 May 2018.

Last reviewed 2018-05-16 · How we verify

NCT03521752

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of an Exercise Program in the Elderly Balance

Completed NA Last updated 16 May 2018

What this trial tests

NA trial testing Specific Exercise Program in Balance; Distorted in 21 participants. Completed in 22 June 2015.

Timeline

4 May 2015

Primary endpoint
14 May 2015

22 June 2015

Quick facts

Lead sponsor	Cooperativa de Ensino Superior, Politécnico e Universitário
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	other
Enrollment	21
Start date	4 May 2015
Primary completion	14 May 2015
Estimated completion	22 June 2015

Drugs / interventions tested

Specific Exercise Program

Conditions studied

Balance; Distorted — all drugs for Balance; Distorted →

Sponsor

Cooperativa de Ensino Superior, Politécnico e Universitário

Who can join

65 and older, any sex, with Balance; Distorted. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study has the objective to determinate the effectiveness of a specific exercise program on balance and functional capacity of the daily activities of institutionalized elderly. It was a randomized controlled trial with a total of 21 elderly that were randomly distributed into experimental (n = 11) and control groups (n=10). The experimental group performed a specific program exercises during 4 weeks, while the control group wasn't subjected to any intervention. Evaluations were carried out at the beginning and end of the exercise program, for both groups. After the intervention there were no statistically significant differences between groups in total balance and dynamic balance subscale, except static balance subscale.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Proceedings of the 4th IPLeiria’s International Health Congress : Leiria, Portugal. 11-12 May 2018
· 2018

Verify or expand the search:

Other recruiting trials for Balance; Distorted

Currently open trials in the same condition.

NCT07174973 — Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis · NA · recruiting
NCT07283276 — Effect of Functional Core Stability Training or Cognitive Training on Balance and Postural Control in Chronic Ankle Inst · NA · recruiting
NCT06845709 — Effects of Otago and Gaze Stabilization Exercises on Balance, Gait and QOL in Elderly Stroke Patients · NA · recruiting
NCT06459544 — Effects of Bobath Approach With Core Stability to Improve Balance in Stroke · NA · active not recruiting
NCT03881930 — Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy · NA · recruiting

Other Cooperativa de Ensino Superior, Politécnico e Universitário trials

Trials by the same sponsor.

NCT07438236 — Cognitive Performance and Mood After Ingestion of Dietary Supplement by University Students · NA · completed
NCT06662578 — Using Equine Therapy in Dementia Cognitive Stimulation · NA · completed
NCT03255538 — Deep Friction Massage: Symptomatic · NA · completed
NCT03255525 — Deep Friction Massage Effects: Asymptomatic · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03521752 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cooperativa de Ensino Superior, Politécnico e Universitário
Last refreshed: 16 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03521752.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing